Fecal microbiota transplantation for patients with ulcerative colitis: a systematic review and meta-analysis of randomized control trials - Summary - MDSpire
Advertisement
Fecal microbiota transplantation for patients with ulcerative colitis: a systematic review and meta-analysis of randomized control trials
To assess the efficacy of fecal microbiota transplantation (FMT) in patients with ulcerative colitis (UC) compared to placebo or standard treatment, including specific therapies.
Key Findings:
FMT may improve clinical and endoscopic remission rates in UC patients, though efficacy varies based on factors such as disease duration and preoperative treatments.
Interpretation:
FMT shows promise as a therapeutic option for UC, but its efficacy is influenced by multiple patient and treatment-related factors.
Limitations:
Variability in donor criteria and FMT protocols across studies may significantly affect outcomes.
Limited number of high-quality RCTs available for analysis.
Potential publication bias affecting the results.
Conclusion:
FMT may be a beneficial treatment for UC, warranting further investigation to optimize protocols and identify patient subgroups that may benefit most, including specific next steps for research.
